Gasdermin and MLKL necrotic cell death effectors: Signaling and diseases

Kate E Lawlor1, James M Murphy2, James E Vince3

  • 1Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia; Department of Molecular and Translational Science, Monash University, Clayton, VIC 3168, Australia; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; The Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.

Immunity
|March 13, 2024
PubMed

Insights

Necrotic cell death, involving MLKL and gasdermin proteins, can trigger inflammation in various diseases. Understanding these cell death pathways is crucial for developing new treatments for inflammatory conditions.

Area of Science:

  • Cellular Biology
  • Immunology
  • Pathology

Background:

  • Inflammatory conditions are linked to cellular damage and death.
  • Apoptotic cell death is anti-inflammatory, while necroptosis and pyroptosis are inflammatory.
  • MLKL and gasdermin proteins drive membrane damage in necrotic cell death.

Purpose of the Study:

  • To review the function and regulation of MLKL and gasdermin.
  • To evaluate the role of MLKL- and gasdermin-driven necrosis in disease.
  • To highlight the need for research on pyroptosis and necroptosis in human tissues.

Main Methods:

  • Literature review of inflammatory conditions.
  • Analysis of genetic evidence from gene-targeted mice studies.
  • Evaluation of MLKL and gasdermin effector proteins.

Main Results:

  • Necroptosis (MLKL) and pyroptosis (gasdermin) drive inflammatory responses.
  • MLKL and gasdermin-driven necrosis can be protective or detrimental in disease.
  • Gene-targeted mice studies provide insights into these pathways.

Conclusions:

  • MLKL and gasdermin are key effectors of inflammatory necrotic cell death.
  • The role of necroptosis and pyroptosis in disease is context-dependent.
  • Further research in human tissues is needed to develop targeted necrotic inhibitors for inflammatory diseases.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K